Latest News

GSK and Innoviva report positive results from clinical study of relvar ellipta for asthma

UK-based pharmaceutical firm GlaxoSmithKline (GSK) and US-based healthcare firm Innoviva have reported positive headline results from a non-inferiority lung function study of relvar ellipta...

GSK and Innoviva report positive results from clinical study of relvar ellipta for asthma

NIH begins Phase I trial of DS-Cav1 to treat respiratory syncytial virus

NIH begins Phase I trial of DS-Cav1 to treat respiratory syncytial virus

Zydus to begin Phase II trial of saroglitazar magnesium to treat PBC

Indian-based healthcare company Zydus Cadila has obtained the US Food and Drug Administration (FDA) approval to begin a Phase II trial of saroglitazar magnesium (Mg) for the treatment of...

Zydus to begin Phase II trial of saroglitazar magnesium to treat PBC

Aeolus initiates Phase I trial of AEOL 10150 in healthy subjects

US-based biotechnology firm Aeolus Pharmaceuticals has initiated a Phase I clinical trial of an AEOL 10150 subcutaneous injection in healthy...

Aeolus initiates Phase I trial of AEOL 10150 in healthy subjects

Trevena reports positive top-line results from two Phase III trials of oliceridine in acute pain

US-based biopharmaceutical company Trevena has reported positive top-line results from two Phase III clinical trials (APOLLO-1 and APOLLO-2) of oliceridine to treat moderate-to-severe acute...

Trevena reports positive top-line results from two Phase III trials of oliceridine in acute pain

ImmusanT's Nexvax2 demonstrates positive outcome in Phase Ib trial to treat coeliac disease

ImmusanT's Nexvax2 demonstrates positive outcome in Phase Ib trial to treat coeliac disease

NIH initiates Phase I trial of AGS-v to prevent mosquito-transmitted diseases

National Institutes of Health (NIH) division the National Institute of Allergy and Infectious Diseases (NIAID) has initiated a Phase I clinical trial of vaccine AGS-v to prevent a range...

NIH initiates Phase I trial of AGS-v to prevent mosquito-transmitted diseases

Bellicum begins dosing in Phase I trial of BPX-601 to treat pancreatic adenocarcinoma

Bellicum begins dosing in Phase I trial of BPX-601 to treat pancreatic adenocarcinoma

Immuron closes enrolment in Phase II trial of IMM-124E in NASH

Australian-based biopharmaceutical company Immuron has closed enrolment in the Phase II clinical trial of its IMM-124E to treat non-alcoholic steatohepatitis (NASH)...

Immuron closes enrolment in Phase II trial of IMM-124E in NASH

Faron commences enrolment in Phase II trial of traumakine to treat MOF in RAAA

Finland-based clinical stage biopharmaceutical firm Faron Pharmaceuticals has commenced enrolment in the Phase II INFORAAA clinical trial of traumakine (FP-1201-lyo) to treat patients...

Faron commences enrolment in Phase II trial of traumakine to treat MOF in RAAA

Celgene reports positive top-line results from Phase III trial of ozanimod to treat RMS

Celgene reports positive top-line results from Phase III trial of ozanimod to treat RMS

Chi-Med begins Phase II trial of savolitinib to treat PSC in China

Biopharmaceutical firm Hutchison China MediTech (Chi-Med) has begun a Phase II clinical trial of savolitinib for the treatment of locally advanced or metastatic pulmonary sarcomatoid...

Chi-Med begins Phase II trial of savolitinib to treat PSC in China

AstraZeneca announces positive results from Phase III trial of Lynparza for breast cancer

Biopharmaceutical firm AstraZeneca has announced positive results from its Phase III clinical trial (OlympiAD) of Lynparza (olaparib) to treat patients with HER2-negative metastatic breast...

AstraZeneca announces positive results from Phase III trial of Lynparza for breast cancer

Tracon commences dosing in Phase III trial of TRC105 to treat angiosarcoma

US-based clinical-stage biopharmaceutical firm Tracon Pharmaceuticals has commenced dosing in its Phase III trial of TRC105 in combination with Votrient (pazopanib) for the treatment of angiosarcoma....

Tracon commences dosing in Phase III trial of TRC105 to treat angiosarcoma

University of Liverpool and AKL collaborate to evaluate APPA for osteoarthritis

University of Liverpool and AKL collaborate to evaluate APPA for osteoarthritis

Ardelyx reports positive results from Phase III trial of tenapanor for hyperphosphatemia

Ardelyx reports positive results from Phase III trial of tenapanor for hyperphosphatemia

Theratechnologies reports comparative PK Data on IM and IV administration of ibalizumab in HIV patients

Pharmaceutical firm Theratechnologies has announced the pharmacokinetics (PK) and pharmacodynamics (PD) data comparing the intramuscular (IM) with the intravenous (IV) administration of...

Theratechnologies reports comparative PK Data on IM and IV administration of ibalizumab in HIV patients

Merck reports positive results from Phase III trial of doravirine to treat HIV-1

Merck reports positive results from Phase III trial of doravirine to treat HIV-1

Sanofi initiates Phase II trial of GZ/SAR402671 to treat Parkinson’s Disease with GBA gene

Sanofi's specialist care global business unit Sanofi Genzyme has initiated a Phase II trial of an investigational oral therapy GZ/SAR402671 to treat patients with Parkinson’s disease, who carry...

Sanofi initiates Phase II trial of GZ/SAR402671 to treat Parkinson’s Disease with GBA gene

Berg begins Phase I/II trial of BPM 31510-IV in patients with glioblastoma multiforme

Biopharmaceutical firm Berg has begun a Phase I/II monotherapy clinical trial of its drug candidate BPM 31510-IV to treat patients with glioblastoma multiforme...

Berg begins Phase I/II trial of BPM 31510-IV in patients with glioblastoma multiforme

Progenics initiates Phase I trial of 1095 to treat metastatic prostate cancer

Progenics initiates Phase I trial of 1095 to treat metastatic prostate cancer